**Core Concept**
Papillary thyroid carcinoma (PTC) is a type of well-differentiated thyroid cancer that accounts for approximately 80-85% of all thyroid cancer cases. It originates from the follicular epithelial cells of the thyroid gland and is characterized by its papillary architecture.

**Why the Correct Answer is Right**
Papillary thyroid carcinoma is often associated with various genetic mutations, including BRAF V600E, which is present in approximately 40-80% of PTC cases. This mutation leads to the constitutive activation of the MAPK signaling pathway, resulting in uncontrolled cell growth and tumor formation. Additionally, PTC is known for its lymphatic spread, with lymph node metastasis being a common feature in up to 80% of cases. The tumor typically exhibits a papillary architecture with nuclear grooves and pseudoinclusions, which are diagnostic features under the microscope.

**Why Each Wrong Option is Incorrect**
**Option A:** PTC is not typically associated with a high level of calcitonin elevation, as it is more commonly seen in medullary thyroid carcinoma.
**Option B:** While PTC can exhibit a range of histological variants, the term "clear cell" is more commonly associated with renal cell carcinoma.
**Option C:** Lymphovascular invasion is not a characteristic feature of PTC, which instead tends to spread through lymphatic channels.

**Clinical Pearl / High-Yield Fact**
PTC is often diagnosed at an early stage, with a good prognosis, but it is essential to recognize its characteristic histological features and genetic mutations to ensure accurate diagnosis and management.

**Correct Answer: C. Papillary thyroid carcinoma often exhibits lymph node metastasis.**